Headlines

NASDAQ:IMGN

Market Movers : ImmunoGen, Inc. (NASDAQ:IMGN), Ford Motor Company (NYSE:F), AT&T, Inc. (NYSE:T), Stanley Black & Decker, Inc. (NYSE:SWK), Computer Programs & Systems Inc. (NASDAQ:CPSI)

Jayne Crisman03 mins

On Oct 10, ImmunoGen, Inc. (NASDAQ:IMGN) announced that the Company will host a conference call at 8:00 a.m. ET on Friday October 24 2014 to discuss ImmunoGen’s financial results for the three-month period ended September 30 2014 the first quarter of its 2015 fiscal year. ImmunoGen, Inc. (NASDAQ:IMGN) belongs to Healthcare sector. Its weekly performance…

Read More

Stocks in Focus : LookSmart, Ltd. (NASDAQ:LOOK), SandRidge Energy, Inc. (NYSE:SD), Apple Inc. (NASDAQ:AAPL), Montage Technology Group Limited (NASDAQ:MONT), ImmunoGen, Inc. (NASDAQ:IMGN)

Adam Keintzel03 mins

LookSmart, Ltd. (NASDAQ:LOOK) gave back some of the gains it accumulated earlier when speculators moved in the stock following Facebook Inc (FB)’s launch of Atlas. The stock declined 10.2% to $2.20 Tuesday. Facebook announced the launching of Atlas, an online marketing service that allows brand to achieve targeted ads on the Web and mobile platforms….

Read More

5 Stocks Under Wall Street’s Radar : Alibaba Group (NYSE:BABA), JD.com, Inc. (NASDAQ:JD), ImmunoGen (NASDAQ:IMGN), Oracle Corporation (NYSE:ORCL), CCA Industries Inc. (NYSEMKT:CAW),

Kristen Barton03 mins

Citi announced that Alibaba Group Holding Ltd (NYSE:BABA) has appointed Citi’s Issuer Services business, acting through Citibank, N.A., as the depositary bank for its American Depositary Receipt (“ADR”) program. Alibaba Group’s ADRs, which began trading on September 19, 2014, represent the largest Depositary Receipt program in initial public offering market history. Alibaba Group Holding Ltd…

Read More

Hot Alert : ImmunoGen (NASDAQ:IMGN), Walt Disney Company (NYSE:DIS), Shanda Games Limited (NASDAQ:GAME), EQT Midstream Partners, LP (NYSE:EQM), Northeast Bancorp (NASDAQ:NBN)

Jason Knox03 mins

The National Institute of Health and Care Excellence (NICE) – the drugs advisory body to the National Health Service (NHS) in the UK – has criticized Roche Holding Ltd. (ADR) (RHHBY) over its refusal to cut prices for Kadcyla, which is used to treat severe cases of breast cancer. Kadcyla is approved to treat HER2-positive…

Read More

Hot Movers: Novartis AG (NYSE:NVS), IMAX Corporation (NYSE:IMAX), ImmunoGen (NASDAQ:IMGN), bluebird bio (NASDAQ:BLUE), Randgold Resources (NASDAQ:GOLD)

Jayne Crisman03 mins

Novartis AG (ADR) (NYSE:NVS) announced today the submission of a Biologic License Application (BLA) to the US Food and Drug Administration (FDA) for marketing approval for the use of Bexsero® (Multicomponent Meningococcal Group B Vaccine [recombinant, adsorbed]) to help protect against invasive meningococcal disease caused by serogroup B (meningitis B) in adolescents and young adults…

Read More

Losers At Healthcare: Synageva BioPharma (NASDAQ:GEVA), Auspex Pharmaceuticals (NASDAQ:ASPX), ImmunoGen (NASDAQ:IMGN), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Mark Doerr02 mins

Synageva BioPharma Corp (NASDAQ:GEVA) last released its earnings data on Friday, May 2nd. The company reported ($1.16) earnings per share for the quarter, beating the analysts’ consensus estimate of ($1.19) by $0.03. Analysts expect that Synageva BioPharma Corp will post $-5.90 EPS for the current fiscal year. Synageva BioPharma Corp (NASDAQ:GEVA)stock performance was 5.87% in…

Read More
Home